Biogen Inc. announced the appointment of Chuck Triano as Senior Vice President, Head of Investor Relations effective 10 April 2023. Mr. Triano will report to Michael McDonnell, Executive Vice President and Chief Financial Officer. Mr. Triano brings over 35 years of financial experience to the role, having held executive positions across prominent biotechnology and pharmaceutical companies over the last two decades, most recently as Chief Financial Officer for Xalud Therapeutics.

Prior to joining Xalud Therapeutics, Mr. Triano served as Senior Vice President of Investor Relations at Pfizer for over a decade, where he was responsible for all global investor relations functions, as well as operations planning and analysis. Previously, he served as the Vice President of Investor Relations at Forest Laboratories, where he initiated the company's first formal investor relations and corporate communications program. He was also a managing director at The Carson Group, a financial information organization specializing in global shareholder research and capital markets intelligence.

He holds a bachelor's degree from the University of Connecticut. Mike Hencke, Executive Director, Investor Relations, and the Investor Relations team will report to Mr. Triano.